Cavtat-Dubrovnik, Croatia
More info
Innate Pharma announces today a capital increase of a maximum of 24.3 million euros reserved to categories of investors
December 18, 2009
- The “Fonds Stratégique d’Investissement” (French sovereign fund) invested 11 million euros
- Novo Nordisk A/S and Alta Partners, two historical shareholders of the Company, also participated in the transaction
| Download Area |
|---|
| PR in english |
| CP en français |